Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crispr Therapeutics Ag
(NQ:
CRSP
)
48.69
+1.19 (+2.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crispr Therapeutics Ag
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
June 27, 2024
These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience.
Via
InvestorPlace
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
June 27, 2024
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions.
Via
InvestorPlace
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."
June 27, 2024
The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon.
Via
The Motley Fool
3 Biotech Stocks That Could Make Your Grandchildren Rich
June 27, 2024
These biotech stocks are poised to generate significant returns to investors due to their high growth potential.
Via
InvestorPlace
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
June 26, 2024
Gene editing is a game-changer, creating substantial opportunities for some of the leading gene editing stocks.
Via
InvestorPlace
3 Gene Editing Stocks That Could Make Your Grandchildren Rich
June 25, 2024
Explore gene-editing stocks with long-term growth potential, offering innovative solutions to previously untreatable conditions.
Via
InvestorPlace
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
May 26, 2024
There are a handful of different factors that could buoy its stock.
Via
The Motley Fool
Is CRISPR Therapeutics a Millionaire Maker?
May 22, 2024
The stars are aligning for it to be a leader for years to come.
Via
The Motley Fool
The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom
June 24, 2024
These three sleeper stocks could deliver massive gains if their cutting-edge technologies take off in the coming years.
Via
InvestorPlace
7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom
June 12, 2024
With so many young people eager to get out of the corporate rat race, these FIRE stocks can accelerate your path and stay free.
Via
InvestorPlace
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
June 09, 2024
These companies could generate explosive growth over time.
Via
The Motley Fool
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
June 04, 2024
In keeping with Cathie Wood's style, these picks are riskier than average.
Via
The Motley Fool
Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You?
May 31, 2024
Teladoc's share performance has reflected its earnings struggles...
Via
The Motley Fool
Is CRISPR Therapeutics Stock a Buy?
May 17, 2024
The gene-editing therapy specialist is rising in prominence.
Via
The Motley Fool
7 Stocks You Haven’t Heard of (That EVERYONE Should Own)
May 29, 2024
These under-the-radar must-own stocks across various sectors are using powerful megatrends and posting solid financial results.
Via
InvestorPlace
7 Biotech Stocks to Put on Your Breakthrough Radar
May 27, 2024
Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance.
Via
InvestorPlace
The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now
May 23, 2024
With interest cuts on the horizon, it's a prime time to consider these high-risk-high-reward biotech stocks to buy.
Via
InvestorPlace
7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition
May 22, 2024
With a modest $1,000 investment, these stocks offer the potential for market-beating gains through solid fundamentals and growth prospects.
Via
InvestorPlace
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
May 22, 2024
These biotech stocks have just launched their first products.
Via
The Motley Fool
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
May 17, 2024
With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.
Via
InvestorPlace
7 No-Brainer Stocks to Buy and Hold for the Next 20 Years: May 2024
May 16, 2024
Here are seven stocks to buy and hold that are poised for long-term growth over the next 20 years and can future-proof your portfolio.
Via
InvestorPlace
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
May 15, 2024
How much would you pay for a stock that might earn $25 a year in six years?
Via
The Motley Fool
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
May 14, 2024
These healthcare stocks offer completely different approaches to long-term investment gains.
Via
The Motley Fool
The 3 Best Cathie Wood Stocks to Buy in May 2024
May 13, 2024
Cathie Wood takes a very risky approach to investing, but she has plenty of great picks. Here are some of the best Cathie Wood stocks to buy.
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
May 11, 2024
Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns.
Via
InvestorPlace
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
May 10, 2024
Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today.
Via
InvestorPlace
Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
May 09, 2024
These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot.
Via
InvestorPlace
CRSP Stock Earnings: CRISPR Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
CRSP stock results show that CRISPR Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
May 04, 2024
Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments.
Via
InvestorPlace
Exposures
Product Safety
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
May 03, 2024
The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.